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Progress in Influenza Surveillance
Marya S. Barker, MPH 
Director, Core Surveillance Section 
Melanie Ratliff, MPH 
Influenza Surveillance Coordinator 
Division of Acute Disease Epidemiology
Over the past decade, DHEC has established a very robust 
influenza surveillance system. It includes the reporting 
of confirmatory tests by individual patient; lab-confirmed 
hospitalizations; influenza-associated deaths; rapid 
antigen tests (RAT); and voluntary Outpatient Influenza-like 
Illness Surveillance Network (ILINET) reporting providers. 
Each of these elements contributes important information 
that allows DHEC to characterize the severity and 
geographic spread and estimate the burden of influenza 
across the state during each annual flu season. 
Hospitalizations and deaths help us monitor the 
epidemiology of severe influenza infections and provide an 
assessment of the severity of the influenza season.
Lab-confirmed cases and rapid tests aid us in identifying 
the type of influenza circulating in the state, detection of 
novel strains, monitoring influenza trends by county and 
regional levels, determining geographic spread of the 
virus, and guiding vaccination efforts.
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ILINET data show us the percent of patient visits in an 
outpatient setting attributed to an influenza-like illness. 
ILI data is a vital component in determining geographic 
spread.
DHEC also monitors national data sources such as the 
National Respiratory and Enteric Virus Surveillance 
System as well as the data from a major influenza testing 
equipment manufacturer as supplements to the state-
mandated requirements.
Each year, the List of Reportable Conditions (List) is 
reviewed to ensure that it will reflect the most appropriate 
conditions requiring public health surveillance at both the 
state and national level. In addition, each data element 
requested must serve a specific and justifiable purpose. 
For 2019, DHEC will no longer require the aggregate 
reporting of RAT. The reason for this decision is three-fold. 
First, the use of rapid molecular assays has significantly 
increased (lab-confirmed cases) providing more robust 
individualized data for influenza infections, e.g. age of 
patient, type of influenza, and geographic location. The 
second reason is RAT reporting only specified collecting 
positives and not total number of tests performed. Without 
this denominator data, we were unable to assess changes 
in provider testing practices or calculate percent positivity. 
Requiring practices to report the total number of tests 
performed, in addition to all the other requirements, 
was not an attractive option. Lastly, based upon the 
methodology adapted by Biggerstaff, M., et. al (2018), data 
from several past seasons were analyzed to determine if 
lab-confirmed influenza tests and RATs were correlated 
and characterized the severity of past influenza seasons 
the same. Findings noted from this evaluation concluded 
that RAT reporting could be eliminated with no loss of 
surveillance quality. 
The rapid antigen test change will appear on the 2019 
List of Reportable Conditions; however, providers can 
stop reporting the RAT to DHEC beginning with the 2018-
2019 influenza season. All other influenza data elements 
remain on the List. For information regarding this reporting 
change, you can refer to: https://scdhec.gov/sites/
default/files/media/document/10420-DHU-09-27-2018-
FLU.pdf
Recent Tuberculosis Control 
Trainings
Vernita Wingate, LMSW, MPH  
TB Program Manager 
Clarissa A. Felima, MPH, CHES  
Health Educator 
Division of Tuberculosis
Tuberculosis and Diabetes 
During August and September 2018, the Division of 
Tuberculosis (TB) Control partnered with the Carolinas 
Center for Medical Excellence (CCME) to coordinate 
Tuberculosis and Diabetes trainings to educate DHEC 
TB Control regional staff on the connection of the two 
morbidities and connect their patients with appropriate 
resources. Almost 40 people attend the one-day training 
held at the Richland County Health Department. DHEC 
offers the course annually.
Advanced TB Today
Since 2012, TB Control has coordinated an Advanced TB 
Today conference, which helps experienced TB Control 
program staff stay current on TB knowledge as well 
as learn new information and skills. TB Control hosted 
an Advanced TB Today conference at the Hyatt Place 
Greenville in Greenville, South Carolina on June 5-7, 2018. 
There were 32 attendees. Resources from the regional 
American Lung Association assisted in this effort. 
Tuberculosis Today
DHEC partnered with the American Lung Association 
(ALA) to sponsor the Tuberculosis (TB) Today workshop 
October 15-17, 2018, at the Hyatt Place in Irmo, SC. 
TB Today is an annual course for healthcare workers 
who provide services to TB patients in South Carolina 
to develop a broad knowledge base in TB. It focuses on 
a practical approach to the current body of knowledge 
on which the treatment and control of tuberculosis is 
based. At the conference, 33 attendees represented 
their respective healthcare settings, including patient 
management, contact investigation, prevention, infection 
control, program management, supervision of staff 
involved in direct care, and professional education. Other 
professionals (e.g., social workers, health educators, 
managers, supervisors, etc.) are encouraged to apply to 
take the course. 
If your facility is interested in a presentation or training on 
TB, please email us at TBControl@dhec.sc.gov with the 
subject line Requesting TB Training.
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Updates to the School and Child 
Care Exclusion List for 2019
Tina Skinner, RN, BSN, MBA  
Nurse Consultant 
Division of Acute Disease Epidemiology
S.C. law requires schools to take measures to prevent 
the spread of disease in the school and childcare 
populations by limiting the attendance of students and 
staff with contagious or infectious diseases at school and 
school activities. SC Regulation #61-20 requires DHEC 
to publish in January of each year an Official School and 
Childcare Exclusion List of Contagious and Communicable 
Diseases, hereinafter referred to as the School and 
Childcare Exclusion List.
Students, employees and staff (including volunteers) 
who have been exposed to one or more of the conditions 
designated in these lists are to be excluded from school or 
childcare attendance until they meet the criteria to return 
to school or childcare.
The following updates were made to the School and 
Childcare Exclusion List for 2019: 
• Shiga toxin-producing E. coli (STEC) cases are to return 
to school/work with documentation of two negative 
results.
• Typhoid fever cases may return to school/work with the 
documentation of three consecutive negative results.
• A brief description of minor illnesses and associated 
outbreak activities.
The School and Child Care Exclusion List for 2019 can 
be found at: https://www.scdhec.gov/sites/default/files/
Library/CR-011634.pdf
Updates to the List of Reportable 
Conditions for 2019
Tashauna Lane 
Data Security Officer/Surveillance System Trainer 
Division of Acute Disease Epidemiology
South Carolina Law 44-29-10 and Regulation 61-20 require 
reporting of conditions on the Official List of Reportable 
Conditions in the manner prescribed by DHEC. Changes in 
reporting criteria for 2019 are listed below.
• Footnote 9: Carbapenem-resistant Enterobacteriaceae 
infections from all specimen types for the following 
species: E. Coli, Enterobacter, and Klebsiella 
was changed to read: Carbapenem-resistant 
Enterobacteriaceae infections from all specimen types.
• Footnote 6: Rabies exposure prophylaxis guidance PCP 
guidance link, was changed to read www.scdhec.gov/
health-professionals/clinical-guidance-resources/
rabies-treatment/rabies-guide-managing-exposures.
• Footnote 13: All blood lead results are reportable within 
30 days. Any elevated results (5 mcg/dL or greater) are 
reportable within seven days.
Updates to Reportable Conditions
• Positive rapid antigen detection tests for Influenza are 
no longer reportable.
• Drug susceptibility profile was added to Carbapenem-
resistant Enterobacteriaceae (CRE). 
• Drug susceptibility profile was added to Carbapenem-
resistant Pseudomonas aeruginosa (CRPA).
South Carolina 2019 List of Reportable Conditions
(L)  Only Labs required to report. 
1. An outbreak is the occurrence of more cases of disease than normally expected within 
a specific place or group of people over a given period of time. Clinical specimens may 
be required.
2. Include drug susceptibility profile
3. Invasive disease = isolated from normally sterile site. Always specify site of isolate.
4. Report Gram-negative diplococcic in blood or CSF.
5. Specimen submission to the Public Health Laboratory is required. Ship immediately 
and urgently reportables within 1 business day. Ship 3 day reportables within 3 
business days. Contact regional staff if assistance is needed.
6. Rabies exposure prophylaxis guidance: www.scdhec.gov/health-professionals/clinical-
guidance-resources/rabies-treatment/rabies-guide-managing-exposures#contacts. 
Consultation is available from DHEC Regional Public Health Office.
7. Report aggregate totals weekly.
8. Report all cases of suspect and confirmed tuberculosis (TB). A suspect case of TB is 
a person whom a health care provider suspects TB based on signs, symptoms, and/or 
laboratory evidence of TB. Centers for Disease Control and Prevention case definition 
of confirmed cases: https://wwwn.cdc.gov/nndss/conditions/tuberculosis.
9. Carbapenem-resistant Enterobacteriaceae infections from all specimen types.
10. Appropriate specimen types: A pure, low passage isolate  submitted on a noninhibitory, 
non-selective agar plate or slant is preferred. If available submit one original culture 
plate.
11. Specimen submission to the Public Health Laboratory is required for Streptococcus 
pneumoniae, invasive in cases < 5 years of age.
12. Specimen submission of the first isolate of the month to the Public Health Laboratory is 
required for Carbapenem-resistant Pseudomonas aeruginosa.
13. All blood lead results are reportable within 30 days. Any elevated results (5 mcg/dL or 
greater) are reportable within 7 days.
!  Any case that may be caused by chemical, biological, or 
radiological threat, novel infectious agent, or any cluster of cases, 
or outbreak of a disease or condition that might pose a substantial 
risk of human morbidity or mortality (1) (5) 
* Animal (mammal) bites (6)
! Anthrax (Bacillus anthracis) (5)
 Babesiosis (Babesia spp.)
! Botulism (Clostridium botulinum or Botulinum toxin)
* Brucellosis (Brucella spp.) (5)
 Campylobacteriosis (5)
 Candida auris or suspected (5)
 Carbapenem-resistant Enterobacteriaceae (CRE) (2) (5) (9)
 Carbapenem-resistant Pseudomonas aeruginosa (CRPA) (2) (5) (12)
 Chancroid (Haemophilus ducreyi)
* Chikungunya (5)
 Chlamydia trachomatis
* Ciguatera
 Creutzfeldt-Jakob Disease (Age < 55 years only)
 Cryptosporidiosis (Cryptosporidium spp.)
 Cyclosporiasis (Cyclospora cayetanensis) (5)
* Dengue (5)
* Diphtheria (Corynebacterium diphtheriae) (5)
* Eastern Equine Encephalitis (EEE) (5)
 Ehrlichiosis / Anaplasmosis (Ehrlichia / Anaplasma phagocytophilum)
* Escherichia coli, Shiga toxin – producing (STEC) (5)
 Giardiasis (Giardia spp.)
 Gonorrhea (Neisseria gonorrhoeae) (2)
* Haemophilus influenzae, all types, invasive disease (H flu) (2) (3) (5)
* Hantavirus
* Hemolytic uremic syndrome (HUS), post-diarrheal
* Hepatitis (acute) A, B, C, D, & E
 Hepatitis (chronic) B, C, & D
 Hepatitis B surface antigen + with each pregnancy
 HIV and AIDS clinical diagnosis
 HIV CD4 test results (all results) (L)
 HIV subtype, genotype, and phenotype (L)
 HIV 1 or HIV 2 positive test results (detection and confirmatory tests) (L)
 HIV viral load (all results) (L)
 HIV HLA-B5701 and co-receptor assay (L)
! Influenza, avian or other novel strain
* Influenza associated deaths (all ages)
 Influenza
• Lab-confirmed cases (culture, RT-PCR, DFA, IFA)
• Lab-confirmed hospitalizations (7)
* La Crosse Encephalitis (LACV) (5)
 Lead tests, all results - indicate venous or capillary specimen (13)
 Legionellosis
 Leprosy (Mycobacterium leprae) (Hansen’s Disease)
 Leptospirosis
 Listeriosis (5)
 Lyme disease (Borrelia burgdorferi)
 Lymphogranuloma venereum
 Malaria (Plasmodium spp.)
! Measles (Rubeola)
! Meningococcal disease (Neisseria meningitidis) (2) (3) (4) (5)
* Mumps
* Pertussis (Bordetella pertussis)
! Plague (Yersinia pestis) (5)
! Poliomyelitis
 Psittacosis (Chlamydophila psittaci)
* Q fever (Coxiella burnetii)
! Rabies (human)
 Rabies Post Exposure Prophylaxis (PEP) when administered (6)
* Rubella (includes congenital)
 Salmonellosis (2) (5)
* Shiga toxin positive (5)
 Shigellosis (2) (5)
! Smallpox (Variola)
 Spotted Fever Rickettsiosis (Rickettsia spp.)
*  Staphylococcus aureus, vancomycin-resistant or intermediate with a   
 VA >6 MIC (VRSA/VISA) (2) (5) (10)
 Streptococcus group A, invasive disease (2) (3)
 Streptococcus group B, age < 90 days (2)
 Streptococcus pneumoniae, invasive (pneumococcal) (2) (3) (11)
* St. Louis Encephalitis (SLEV) (5)
*  Syphilis: congenital, primary, or secondary (lesion or rash) or Darkfield 
positive
 Syphilis: early latent, latent, tertiary, or positive serological test
 Tetanus (Clostridium tetani)
 Toxic Shock (specify staphylococcal or streptococcal)
* Tuberculosis (Mycobacterium tuberculosis) (5) (8)
* Tularemia (Francisella tularensis) (5)
* Typhoid fever (Salmonella typhi) (2) (5)
* Typhus, epidemic (Rickettsia prowazekii)
 Varicella
* Vibrio, all types, including Vibrio cholerae O1 and O139 (5)
! Viral Hemorrhagic Fevers (Ebola, Lassa, Marburg viruses)
* West Nile Virus (5)
* Yellow Fever
 Yersiniosis (Yersinia, not pestis)
* Zika (5)
Attention: Health Care Facilities, Physicians, and Laboratories
South Carolina Law §44-29-10 and Regulation §61-20 require reporting of conditions on 
this list to the regional public health department. South Carolina Law §44-53-1380 requires 
reporting by laboratories of all blood lead values in children under 6 years of age.
HIPAA: Federal HIPAA legislation allows disclosure of protected health information, 
without consent of the individual, to public health authorities for the purpose of 
preventing or controlling disease. (HIPAA 45 CFR §164.512)
REPORT UPON RECOGNITION OF A SUSPECTED CASE, DIAGNOSIS, OR POSITIVE LABORATORY EVIDENCE (SEE “HOW TO REPORT” ON BACK)
Suspected means clinical suspicion and/or initial laboratory detection, isolation, identification, or presence of supportive laboratory results.
   Potential agent of bioterrorism
!   Immediately reportable by phone call to a live 
person at the regional public health office, 24/7
*   Urgently reportable within 24 hours by phone 
All other conditions except lead are reportable 
within 3 business days
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WHAT TO REPORT
For all suspected and confirmed cases, report the 
following:
• Patient’s name 
• Patient’s complete address, phone, county, date 
of birth, race, sex, last five digits of social security 
number
• Physician’s name and phone number
• Name, institution, and phone number of person 
reporting 
• Disease or condition 
• Date of diagnosis 
• Symptoms
• Date of onset of symptoms
• Lab results, specimen site, collection date
• If female, pregnancy status 
• Patient status: In childcare, food-handler, healthcare 
worker, childcare worker, nursing home, prisoner/
detainee, travel in the past four weeks
HOW TO REPORT
HIV, AIDS, and STDs (excluding Hepatitis):
Do not fax HIV, AIDs, or STD results to DHEC.
• Call 1-800-277-0873;
• Submit electronically via DHEC’s web-based 
reporting system; or
• Mail to:  Division of Surveillance & Technical Support  
Mills/Jarrett Complex 
Box 101106, Columbia, SC 29211
LEAD:
• Mail to:  Bureau of Health Improvement & Equity, Lead 
Surveillance 
c/o Brian Humphries 
Sims-Aycock Building 
2600 Bull Street, Columbia, SC 29201
• Fax: (803) 898-3236
• Call (803) 898-3641 to establish electronic reporting.
Reporting reminders• Drug susceptibility profiles are no longer required for 
“Lab confirmed cases of Influenza.”
• Drug susceptibility profiles are no longer required for 
Camplyobacterosis.
• Cyclosporiais (Cyclospora) was changed to read: 
Cyclosporiasis (Cyclospora cayetanensis).
• Cyclosporiasis (Cyclospora cayetanensis) Specimen 
submission to the Public Health Laboratory is required. 
Ship three-day reportables within three days.
• Appropriate specimen types: A pure, low passage 
isolate submitted on a non-inhibitory, non-selective 
agar plate or slant is preferred. If available submit one 
original culture plate; was added to “Staphylococcus 
aureus, vancomycin-resistant or intermediate” with a 
VA > 6 MIC (VRSA/VISA).
• Footnote (10) was removed from Carbapenem-resistant 
Enterobacteriaceae (CRE).
• Footnote (10) was removed form Carbapenem-resistant 
Pseudomonas aeruginosa (CRPA). 
• Babesiosis (Babesia microti) was changed to read: 
Babesiosis (Babesia spp.).
• Brucellosis (Brucella) was changed to read: Brucellosis 
(Brucella spp.).
• Cryptosporidiosis (Cryptosporidium) was changed to 
read: Cryptosporidiosis (Cryptosporidium spp.).
• Giardiasis (Giardia) was changed to read: Giardiasis 
(Giardia spp.).
• Malaria (Plasmodium) was changed to read: Malaria 
(Plasmodium spp.).
• Rocky Mountain Spotted Fever (Rickettsia rickettsii) 
(Spotted Fever group) was changed to read: Spotted 
Fever Rickettsiosis (Rickettsia spp).
• Influenza A, avian or other novel strain was changed to 
read: Influenza, avian or other Novel Strain.
Conditions Added
• Candida Auris or suspected, has been added to 
reportable within 24 Hours by phone. Specimen 
submission to the Public Health Laboratory is required.
Conditions Removed
• Trichinellosis (Trichinella spiralis) is no longer 
reportable.
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This section’s layout was updated to reflect the changes in the telephone numbers for the Pee Dee region (Chesterfield, 
Clarendon, Darlington, Florence, Lee, Marlboro, Sumter, and Williamsburg). TB must be reported to the public health office 
in the region in which the patient resides.
WHERE TO REPORT OTHER CONDITIONS
Report all other conditions to the public health office (listed below) in the region in which the patient resides.
Immediate and Urgent Reporting (TELEPHONE)
Lowcountry
Berkeley, Charleston,  
Dorchester
Phone: (843) 953-0043
Beaufort, Colleton,  
Hampton, Jasper
Phone: (843) 549-1516 
ext. 218
Allendale, Bamberg,  
Calhoun, Orangeburg 
Phone: (803) 268-5833
Nights/Weekends
Phone: (843) 441-1091
Midlands
Kershaw, Lexington,  
Newberry, Richland
Phone: (803) 576-2749
Chester, Fairfield,  
Lancaster, York
Phone: (803) 286-9948
Aiken, Barnwell,  
Edgefield, Saluda
Phone: (803) 642-1618
Nights/Weekends
Phone: (888) 801-1046
Pee Dee
Chesterfield, 
Darlington, Dillon, 
Florence, Marion, 
Marlboro
Phone: (843) 661-4830
Clarendon, Lee, Sumter 
Phone: (803) 773-5511
Georgetown, Horry, 
Williamsburg 
Phone: (843) 915-8800
Nights/Weekends
Phone: (843) 915-8845
Upstate
Anderson, Oconee
Phone: (864) 260-5581
Abbeville, Greenwood, 
McCormick
Phone: (864) 260-5581 
Cherokee, Greenville, 
Laurens, Pickens, 
Spartanburg, Union
Phone: (864) 372-3133
Nights/Weekends
Phone: (866) 298-4442
3-Day Reporting (MAIL or FAX)
Lowcountry
4050 Bridge View Drive, Suite 600
N. Charleston, SC 29405
Fax: (843) 953-0051
Midlands
2000 Hampton Street
Columbia, SC 29204
Fax: (803) 576-2993
Pee Dee
145 E. Cheves Street
Florence, SC 29506
Fax: (843) 915-6502
Upstate
200 University Ridge
Greenville, SC 29602
Fax: (864) 282-4373
Lowcountry
Berkeley, Charleston, Dorchester
Office: (843) 719-4612
Fax: (843) 719-4778
Allendale, Bamberg, Beaufort, 
Calhoun, Colleton, Hampton, 
Jasper, Orangeburg
Office: (843) 549-1516 ext. 222
Fax: (843) 549-6845
Midlands
Chester, Kershaw, Lancaster, 
Newberry, York
Office: (803) 909-7357
Fax: (803) 327-4391
Aiken, Barnwell, Edgefield, 
Fairfield, Lexington,  
Richland, Saluda
Office: (803) 576-2870
Fax: (803) 576-2880
Pee Dee
Dillon, Georgetown, Horry, 
Marion
Office: (843) 915-8798
Fax: (843) 915-6504
Chesterfield, Clarendon, 
Darlington, Florence, Lee, 
Marlboro, Sumter, Williamsburg
Office: (843) 934-2867
Fax: (843) 773-6366
Upstate
Cherokee, Spartanburg, Union
Office: (864) 596-2227 ext. 108
Fax: (864) 596-3340
Abbeville, Anderson,  
Greenwood, Laurens, 
McCormick, Oconee, Pickens
Office: (864) 260-5562
Fax: (864) 260-5564
Greenville
Office: (864) 372-3198
Fax: (864) 282-4294
WHERE TO REPORT TUBERCULOSIS
Report to the public health office (listed below) in the region in which the patient resides.
Nights/Weekends/Holidays: (803) 898-0558 Fax: (803) 898-0685
This section’s layout was updated to reflect the changes in the telephone numbers for the Pee Dee region (Georgetown, 
Horry, Williamsburg). All conditions other than HIV, AIDS, STDs, Lead and TB must be reported to the public health office 
in the region in which the patient resides. Immediately and urgently reportable conditions must be reported by telephone. 
Conditions which are routinely reportable must be reported via mail, fax or submitted electronically via DHEC’s web-based 
reporting system.
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Links for Disease Reporting Information
Reportable Diseases Page on DHEC website
www.scdhec.gov/health-professionals/report-diseases-
adverse-events/south-carolina-list-reportable-
conditions 
PDF List of Reportable Conditions
https://www.scdhec.gov/sites/default/files/Library/CR-
009025.pdf
SC DHEC Disease Reporting Form
www.scdhec.gov/sites/default/files/Library/D-1129.pdf
Questions?
For questions about Disease Reporting or to discuss 
electronic disease reporting via DHEC’s electronic disease 
surveillance reporting system, call the DHEC Bureau of 
Disease Control in Columbia: 
(803) 898-0861 
Monday – Friday 
8:30 a.m. – 5 p.m. 
To learn about DHEC’s web-based reporting system, call:
1-800-917-2093 
Monday – Friday 
8:30 a.m. – 5 p.m.
